Somatostatin

Category
peptide
Half-Life (t½)
IV: 2m
Formula
C76H104N18O19S2
Molecular Weight
1637.9 g/mol
PubChem CID
16129706
Aliases
SST, SST-14, SST-28, Growth-hormone-inhibiting hormone (GHIH)

Pharmacological Mechanism

Two primary forms (SST-14, SST-28) produced from preprosomatostatin. Binds SSTR1-5 (5 GPCR subtypes). Broad inhibitory profile: blocks GH, insulin, glucagon, gastrin, secretin, VIP, and motilin release; also inhibits CNS neurotransmission. Extremely short plasma t½ (~2 min) mandates continuous infusion. Clinical analogs octreotide, lanreotide, and pasireotide carry the same profile with extended t½.

Half-Life & Elimination Curve (IV: 2m)

100%50%25%12.5%0%0h0×t½2m1×t½4m2×t½6m3×t½8m4×t½10m5×t½0×t½ (0h): 100% remaining1×t½ (2m): 50% remaining2×t½ (4m): 25% remaining3×t½ (6m): 12.5% remaining4×t½ (8m): 6.3% remaining5×t½ (10m): 3.1% remaining
Elimination (IV)
  • 0×t½0h100%
  • 1×t½2m50%
  • 2×t½4m25%
  • 3×t½6m12.5%
  • 4×t½8m6.3%
  • 5×t½10m3.1%
Elimination t½2m (IV)
Rate Constant (ke)21 h⁻¹
97% Washout (5×t½)10m

Dosing Guidelines

Pharmacokinetic Parameters

Pathways It Modulates

Target Organ Systems

Chemical Structure & Identifiers

References